Organigram Global Inc. OGI

Company Overview

Organigram Global Inc. is a Canadian cannabis company focused on the cultivation, production, and distribution of cannabis products for both adult-use and medical markets. The company operates primarily within the regulated cannabis industry and generates revenue through the sale of dried flower, pre-rolls, cannabis oils, edibles, vapes, and infused products. Organigram’s core business is centered on branded cannabis products sold through provincial distributors and authorized retailers in Canada, while also pursuing international medical cannabis opportunities and strategic investments in cannabis-related technologies and businesses.

The company’s principal business units include Organigram Inc., Laurentian Organic Inc., and consumer-facing cannabis brands such as Edison, SHRED, Monjour, Big Bag O’ Buds, and Trailblazer. Organigram has positioned itself as a scale producer with a diversified product portfolio across multiple consumer price categories, particularly in the value and mainstream segments of the Canadian recreational cannabis market. Founded in 2010 and headquartered in Moncton, New Brunswick, the company evolved from a medical cannabis producer into a multi-brand consumer cannabis company following the legalization of adult-use cannabis in Canada in 2018. Public filings and financial disclosures indicate the company has increasingly emphasized operational efficiency, automation, and brand-driven market share growth.

Business Operations

Organigram generates revenue primarily through the production and sale of recreational cannabis products in Canada, with additional revenue streams from international medical cannabis exports and wholesale activities. Its operations are anchored by its indoor cultivation and manufacturing campus in Moncton, which serves as the company’s primary production and processing facility. The company operates across several major business categories including dried flower, pre-rolls, edibles, vape cartridges, concentrates, and cannabis beverages. Organigram has also developed proprietary nano-emulsion and formulation technologies used in ingestible cannabis products through its innovation-focused operations.

The company maintains domestic distribution relationships with provincial cannabis boards and retailers across Canada and has pursued international expansion through exports to markets including Australia, Germany, and the United Kingdom where regulations permit medical cannabis imports. Organigram has also expanded through acquisitions and partnerships, including the acquisition of Laurentian Organic Inc., a Québec-based cannabis producer, which strengthened its presence in the premium organic cannabis category. Public disclosures also reference strategic collaboration and investment initiatives connected to cannabinoid science, biosynthesis, and product innovation.

Strategic Position & Investments

Organigram’s strategic direction has focused on strengthening branded market share in Canada while investing selectively in international growth and cannabis-related innovation. The company has emphasized operational discipline, cultivation efficiency, automation, and higher-margin derivative products as central drivers of profitability. Organigram has also pursued category expansion in edibles and infused pre-rolls, segments that have experienced growth within the Canadian adult-use market. Management commentary in public filings has consistently highlighted the importance of brand recognition, supply chain optimization, and consumer product differentiation.

A major strategic development has been Organigram’s partnership and investment relationship with British American Tobacco plc through the creation of Centre of Excellence (COE) initiatives focused on next-generation cannabis products and cannabinoid research. The company has also established investment vehicles and strategic funds targeting emerging cannabis technologies and intellectual property opportunities. Acquisitions such as Laurentian Organic Inc. have supported diversification into premium and organic product categories, while ongoing investments in automation and advanced cultivation technologies aim to improve production consistency and cost competitiveness.

Geographic Footprint

Organigram is headquartered in Moncton, New Brunswick, Canada, where it operates its principal cultivation, manufacturing, and product development facilities. The company’s largest market remains Canada, where its products are distributed nationally through provincial cannabis distribution systems and licensed retail channels. Organigram maintains market exposure across multiple Canadian provinces including Ontario, Québec, British Columbia, and Alberta, which collectively represent the largest legal cannabis markets in the country.

Internationally, Organigram has pursued medical cannabis export opportunities and strategic relationships in select regulated markets. Public disclosures identify activity in regions including Europe, Australia, and parts of the Commonwealth medical cannabis market. While international revenue remains smaller relative to domestic operations, the company has indicated continued interest in expanding global medical cannabis distribution and leveraging international regulatory developments where commercially viable.

Leadership & Governance

Organigram operates under a corporate governance structure led by an executive management team and board of directors with experience in consumer products, regulated industries, finance, and operations. The company’s leadership strategy has emphasized disciplined capital allocation, product innovation, brand development, and long-term operational sustainability within a highly regulated and competitive cannabis market.

Key executives include:

• Beena Goldenberg – Chief Executive Officer
• Derrick West – Chief Financial Officer
• Tim Emberg – Chief Commercial Officer
• Paolo De Luca – Chief Strategy Officer
• Megan McCrae – Senior Vice President, Human Resources
• Carlton Crocker – Senior Vice President, Operations

Leadership communications in public filings and investor materials consistently emphasize profitability, innovation, consumer-centric branding, and responsible growth. Governance practices are disclosed through annual reporting documents including SEC filings, Canadian securities filings, and annual management information circulars.